KRRO

Korro Bio, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website korrobio.com
Employees(FY) 95
ISIN US5009461089

Performance

-11.39%

1W

-20.14%

1M

-10.15%

3M

+248.9%

6M

+12.69%

YTD

+180.57%

1Y

Profile

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

Advanced Technical Analysis

Technical Analysis of KRRO 2024-05-03

Overview:

In analyzing the technical indicators for KRRO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and recommendations for potential...

See more ...

Recent News & Updates

2024-04-18 08:30
Korro Announces $70 Million Private Placement(GlobeNewswire)
2024-04-17 20:30
Korro Announces $70 Million Private Placement(Globenewswire)
2024-04-01 16:01
Korro to Participate in Upcoming Investor Conferences(GlobeNewswire)
2024-04-01 04:01
Korro to Participate in Upcoming Investor Conferences(Globenewswire)
2024-03-26 16:01
Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress(GlobeNewswire)
2024-03-26 04:01
Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress(Globenewswire)
2024-02-27 08:00
Korro to Present at the TD Cowen 44th Annual Health Care Conference(GlobeNewswire)
2024-02-26 20:55
Wall Street Analysts Believe Korro Bio, Inc. (KRRO) Could Rally 86.94%: Here's is How to Trade(Zacks)
2024-02-26 19:00
Korro to Present at the TD Cowen 44th Annual Health Care Conference(Globenewswire)
2024-02-08 20:55
Does Korro Bio, Inc. (KRRO) Have the Potential to Rally 59.66% as Wall Street Analysts Expect?(Zacks)
2024-02-06 05:53
Private equity firms are Korro Bio, Inc.'s (NASDAQ:KRRO) biggest owners and were rewarded after market cap rose by US$161m last week(Simply Wall St.)
2024-01-18 08:00
Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio(GlobeNewswire)
2024-01-17 19:00
Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio(Globenewswire)
2024-01-04 08:00
Korro to Present at the 42nd Annual J.P. Morgan Healthcare Conference(GlobeNewswire)
2024-01-03 19:00
Korro to Present at the 42nd Annual J.P. Morgan Healthcare Conference(Globenewswire)
2023-12-07 08:00
Korro Announces Selection of its First Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)(GlobeNewswire)
2023-12-06 19:00
Korro Announces Selection of its First Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)(Globenewswire)
2023-11-28 08:00
Korro Bio Appoints Dr. Rachel Meyers to Board of Directors(GlobeNewswire)
2023-11-27 19:00
Korro Bio Appoints Dr. Rachel Meyers to Board of Directors(Globenewswire)
2023-11-03 03:31
UPDATE: Korro Bio and Frequency Therapeutics Announce Closing of Merger and Private Placement of $117 Million(Globenewswire)
2023-11-03 00:19
Korro Bio and Frequency Therapeutics Announce Closing of Merger and Private Placement of $117 Million(Globenewswire)
2023-08-10 04:01
Frequency Therapeutics Provides Business Updates and Second Quarter 2023 Financial Results(Yahoo Finance)
2023-07-16 23:59
Frequency (FREQ) Up 77% on Merger Deal With Korro Bio(Yahoo Finance)
2023-07-13 23:22
Why Are Frequency Therapeutics Shares Surging Today(Yahoo Finance)
2023-07-13 18:30
Korro Bio and Frequency Therapeutics Announce Merger Agreement(Yahoo Finance)
2023-05-12 04:01
Frequency Therapeutics Provides Business Updates and First Quarter 2023 Financial Results(Yahoo Finance)
2023-03-09 18:30
Frequency Therapeutics Provides Business Updates and Fourth Quarter and Full Year 2022 Financial Results(Yahoo Finance)
2023-02-26 18:30
Frequency Therapeutics to Participate at Upcoming March Investor Conferences(Yahoo Finance)
2023-02-13 00:55
Hearing loss startup to cut more than half of staff in wake of trial failure(Yahoo Finance)
2023-02-12 22:17
Frequency Therapeutics' Lead Hearing Loss Program Flunks, Shifts Focus To Multiple Sclerosis, Shares Plunge(Yahoo Finance)

Page 1 of 4

previousnext